Katherine Bowdish Email

CEO . PIC Therapeutics

Current Roles

Employees:
13
Revenue:
$1M
About
PIC Therapeutics is a biotechnology company focused on fundamentally changing how we treat cancer by developing a new generation of therapeutics based on the modulation of RNA translation. PIC Therapeutics was founded on the seminal work of Dr. Gerhard Wagner, a professor at Harvard Medical School world-renowned for his scientific expertise in protein structure and his research on interactions of eukaryotic translation initiation factors (eIFs). PIC Therapeutics, led by President and CEO Dr. Kathy Bowdish, was launched to translate these discoveries into small molecule precision therapeutics to benefit cancer patients. Our precision-based therapeutics target the “master switch” of cancer signaling pathways, selectively blocking oncogene protein production by modulating the Pre-Initiation Complex (PIC) that drives their mRNA translation. Our selective approach has the potential to simultaneously modulate multiple oncogenic drivers leading to a powerful new generation of cancer-treating therapeutics.
PIC Therapeutics Address
22 Strathmore Road
Natick, MA
PIC Therapeutics Email

Past Companies

PIC TherapeuticsChief Executive Officer
ADOCIABoard Member
Women In Bio - Engage. Educate. Empower.Executive Women in Bio 2020 Boardroom Ready Member

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.